vs
Chord Energy Corp（CHRD）与Revvity（RVTY）财务数据对比。点击上方公司名可切换其他公司
Chord Energy Corp的季度营收约是Revvity的1.5倍（$1.2B vs $772.1M），Revvity净利率更高（12.7% vs 7.2%，领先5.5%），Revvity同比增速更快（5.9% vs -19.6%），过去两年Revvity的营收复合增速更高（9.0% vs 3.8%）
Chord Energy Corp（前身为绿洲石油）是一家从事油气勘探、水力压裂业务的能源企业，核心运营区域位于美国北达科他州与蒙大拿州的威利斯顿盆地，注册地为特拉华州，总部设在得克萨斯州休斯敦，在北达科他州威利斯顿设有办事处。
Revvity是一家美国生命科学与诊断领域企业，主要服务制药、生物技术行业客户，重点围绕细胞治疗、基因治疗等前沿技术领域提供相关产品与解决方案，其前身为业务布局多元的老牌企业珀金埃尔默。
CHRD vs RVTY — 直观对比
营收规模更大
CHRD
是对方的1.5倍
$772.1M
营收增速更快
RVTY
高出25.5%
-19.6%
净利率更高
RVTY
高出5.5%
7.2%
两年增速更快
RVTY
近两年复合增速
3.8%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $1.2B | $772.1M |
| 净利润 | $84.4M | $98.4M |
| 毛利率 | — | — |
| 营业利润率 | 7.9% | 14.5% |
| 净利率 | 7.2% | 12.7% |
| 营收同比 | -19.6% | 5.9% |
| 净利润同比 | -59.9% | 3.9% |
| 每股收益（稀释后） | $1.59 | $0.86 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收CHRDRVTY
| Q4 25 | $1.2B | $772.1M | ||
| Q3 25 | $1.3B | $698.9M | ||
| Q2 25 | $1.2B | $720.3M | ||
| Q1 25 | $1.2B | $664.8M | ||
| Q4 24 | $1.5B | $729.4M | ||
| Q3 24 | $1.5B | $684.0M | ||
| Q2 24 | $1.3B | $691.7M | ||
| Q1 24 | $1.1B | $649.9M |
净利润CHRDRVTY
| Q4 25 | $84.4M | $98.4M | ||
| Q3 25 | $130.1M | $46.7M | ||
| Q2 25 | $-389.9M | $53.9M | ||
| Q1 25 | $219.8M | $42.2M | ||
| Q4 24 | $210.6M | $94.6M | ||
| Q3 24 | $225.3M | $94.4M | ||
| Q2 24 | $213.4M | $55.4M | ||
| Q1 24 | $199.4M | $26.0M |
毛利率CHRDRVTY
| Q4 25 | — | — | ||
| Q3 25 | 74.0% | 53.6% | ||
| Q2 25 | — | 54.5% | ||
| Q1 25 | — | 56.5% | ||
| Q4 24 | — | — | ||
| Q3 24 | 77.3% | 56.3% | ||
| Q2 24 | — | 55.7% | ||
| Q1 24 | — | 54.6% |
营业利润率CHRDRVTY
| Q4 25 | 7.9% | 14.5% | ||
| Q3 25 | 13.0% | 11.7% | ||
| Q2 25 | -34.2% | 12.6% | ||
| Q1 25 | 27.8% | 10.9% | ||
| Q4 24 | 18.2% | 16.3% | ||
| Q3 24 | 18.8% | 14.3% | ||
| Q2 24 | 22.9% | 12.4% | ||
| Q1 24 | 25.1% | 6.8% |
净利率CHRDRVTY
| Q4 25 | 7.2% | 12.7% | ||
| Q3 25 | 9.9% | 6.7% | ||
| Q2 25 | -33.0% | 7.5% | ||
| Q1 25 | 18.1% | 6.4% | ||
| Q4 24 | 14.5% | 13.0% | ||
| Q3 24 | 15.5% | 13.8% | ||
| Q2 24 | 16.9% | 8.0% | ||
| Q1 24 | 18.4% | 4.0% |
每股收益（稀释后）CHRDRVTY
| Q4 25 | $1.59 | $0.86 | ||
| Q3 25 | $2.26 | $0.40 | ||
| Q2 25 | $-6.77 | $0.46 | ||
| Q1 25 | $3.66 | $0.35 | ||
| Q4 24 | $3.53 | $0.77 | ||
| Q3 24 | $3.59 | $0.77 | ||
| Q2 24 | $4.25 | $0.45 | ||
| Q1 24 | $4.65 | $0.21 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $189.5M | $919.9M |
| 总债务越低越好 | $1.5B | — |
| 股东权益账面价值 | $8.1B | $7.3B |
| 总资产 | $13.1B | $12.2B |
| 负债/权益比越低杠杆越低 | 0.18× | — |
8季度趋势，按日历期对齐
现金及短期投资CHRDRVTY
| Q4 25 | $189.5M | $919.9M | ||
| Q3 25 | $629.2M | $931.4M | ||
| Q2 25 | $40.5M | $991.8M | ||
| Q1 25 | $35.8M | $1.1B | ||
| Q4 24 | $37.0M | $1.2B | ||
| Q3 24 | $52.0M | $1.2B | ||
| Q2 24 | $197.4M | $2.0B | ||
| Q1 24 | $296.4M | $1.7B |
总债务CHRDRVTY
| Q4 25 | $1.5B | — | ||
| Q3 25 | $1.5B | — | ||
| Q2 25 | $918.9M | — | ||
| Q1 25 | $798.8M | — | ||
| Q4 24 | $842.6M | — | ||
| Q3 24 | $867.2M | — | ||
| Q2 24 | $1.0B | — | ||
| Q1 24 | $396.3M | — |
股东权益CHRDRVTY
| Q4 25 | $8.1B | $7.3B | ||
| Q3 25 | $8.1B | $7.4B | ||
| Q2 25 | $8.1B | $7.6B | ||
| Q1 25 | $8.6B | $7.6B | ||
| Q4 24 | $8.7B | $7.7B | ||
| Q3 24 | $8.8B | $7.9B | ||
| Q2 24 | $8.8B | $7.9B | ||
| Q1 24 | $5.1B | $7.8B |
总资产CHRDRVTY
| Q4 25 | $13.1B | $12.2B | ||
| Q3 25 | $13.1B | $12.1B | ||
| Q2 25 | $12.5B | $12.4B | ||
| Q1 25 | $13.1B | $12.4B | ||
| Q4 24 | $13.0B | $12.4B | ||
| Q3 24 | $13.0B | $12.8B | ||
| Q2 24 | $13.1B | $13.4B | ||
| Q1 24 | $7.0B | $13.4B |
负债/权益比CHRDRVTY
| Q4 25 | 0.18× | — | ||
| Q3 25 | 0.18× | — | ||
| Q2 25 | 0.11× | — | ||
| Q1 25 | 0.09× | — | ||
| Q4 24 | 0.10× | — | ||
| Q3 24 | 0.10× | — | ||
| Q2 24 | 0.12× | — | ||
| Q1 24 | 0.08× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $405.0M | $182.0M |
| 自由现金流经营现金流 - 资本支出 | — | $161.8M |
| 自由现金流率自由现金流/营收 | — | 21.0% |
| 资本支出强度资本支出/营收 | — | 2.6% |
| 现金转化率经营现金流/净利润 | 4.80× | 1.85× |
| 过去12个月自由现金流最近4个季度 | — | $509.4M |
8季度趋势，按日历期对齐
经营现金流CHRDRVTY
| Q4 25 | $405.0M | $182.0M | ||
| Q3 25 | $559.0M | $138.5M | ||
| Q2 25 | $419.8M | $134.3M | ||
| Q1 25 | $656.9M | $128.2M | ||
| Q4 24 | $566.5M | $174.2M | ||
| Q3 24 | $663.2M | $147.9M | ||
| Q2 24 | $460.9M | $158.6M | ||
| Q1 24 | $406.7M | $147.6M |
自由现金流CHRDRVTY
| Q4 25 | — | $161.8M | ||
| Q3 25 | — | $120.0M | ||
| Q2 25 | — | $115.5M | ||
| Q1 25 | — | $112.2M | ||
| Q4 24 | — | $149.8M | ||
| Q3 24 | — | $125.6M | ||
| Q2 24 | — | $136.6M | ||
| Q1 24 | — | $129.7M |
自由现金流率CHRDRVTY
| Q4 25 | — | 21.0% | ||
| Q3 25 | — | 17.2% | ||
| Q2 25 | — | 16.0% | ||
| Q1 25 | — | 16.9% | ||
| Q4 24 | — | 20.5% | ||
| Q3 24 | — | 18.4% | ||
| Q2 24 | — | 19.7% | ||
| Q1 24 | — | 20.0% |
资本支出强度CHRDRVTY
| Q4 25 | — | 2.6% | ||
| Q3 25 | — | 2.6% | ||
| Q2 25 | — | 2.6% | ||
| Q1 25 | — | 2.4% | ||
| Q4 24 | — | 3.4% | ||
| Q3 24 | — | 3.3% | ||
| Q2 24 | — | 3.2% | ||
| Q1 24 | — | 2.7% |
现金转化率CHRDRVTY
| Q4 25 | 4.80× | 1.85× | ||
| Q3 25 | 4.30× | 2.97× | ||
| Q2 25 | — | 2.49× | ||
| Q1 25 | 2.99× | 3.03× | ||
| Q4 24 | 2.69× | 1.84× | ||
| Q3 24 | 2.94× | 1.57× | ||
| Q2 24 | 2.16× | 2.87× | ||
| Q1 24 | 2.04× | 5.67× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
CHRD
| Oil Production | $801.0M | 68% |
| Purchased Oil Sales | $285.8M | 24% |
| Natural Gas And Natural Gas Liquid Services | $75.6M | 6% |
| Purchased Gas Sales | $7.0M | 1% |
RVTY
| Immunodiagnostics | $240.8M | 31% |
| Life Sciences | $191.4M | 25% |
| Reproductive Health | $149.3M | 19% |
| Segment Operating Income | $132.0M | 17% |
| Software | $62.3M | 8% |
